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S U M M A R Y
Objectives: Although the application of cardiac implantable electronic devices (CIED) has greatly
increased over the past few decades, CIED endocarditis is becoming a challenging scenario in clinical
practice. Recently, Staphylococcus lugdunensis has emerged as a pathogen in CIED endocarditis. However,
a detailed phenotypic characterization has not been addressed.
Methods: We conducted a systematic literature review covering the period between 1989 and 2011
using the PubMed, Medline, Cochrane, and Embase databases. All cases included had a CIED in use and
met the modiﬁed Duke criteria for infective endocarditis, and all had isolates of S. lugdunensis. The
clinical features, predisposing conditions, echocardiographic ﬁndings, and therapeutic strategies/
outcomes were evaluated. Polymorphonuclear neutrophil functions were examined to test whether the
defect of innate immunity may play a permissive role in host susceptibility to tissue destruction in S.
lugdunensis endocarditis.
Results: Eleven patients with CIED endocarditis caused by S. lugdunensis were identiﬁed. Their mean age
was 61.7  11.2 years, and there was a male preponderance (72.7%). Six patients (54.5%) had undergone re-
manipulation of the pacing system within a few months to years before the occurrence of clinical symptoms.
The median time of symptoms before the diagnosis of CIED endocarditis was 60 days. On echocardiography,
vegetations in the CIED were detected in nine cases (81.8%). Nine patients (81.8%) underwent surgical
removal of the entire device, and one patient received medical treatment alone. The overall mortality rate
was 18.2%. One patient had a septic perforation of the ventricular septum, with a high serum level of N-
terminal prohormone of brain natriuretic peptide (NT-pro-BNP) in the absence of pump failure. The
assessment of polymorphonuclear neutrophil (PMN) functions revealed normal PMN responses to the
various stimuli and normal oxidative burst responses.
Conclusions: Identiﬁcation and differentiation of staphylococcal species in a timely manner would allow
us to intervene more aggressively at an earlier stage to prevent unfavorable outcomes. Clinicians should
never consider the isolation of S. lugdunensis as contamination. In selected individuals, therapeutic
abstention may be preferable to exposing patients to a high risk of S. lugdunensis CIED endocarditis due to
re-manipulation of the pacing system. The prognostic value of NT-pro-BNP warrants further
investigations.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Although the application of cardiac implantable electronic
devices (CIED) has greatly increased over the past few decades,
the management of CIED endocarditis remains challenging. A wide
variety of pathogens have been described, however Staphylococcus* Corresponding author. Tel.: +886 2 87927120; fax: +886 2 87927057.
E-mail address: weiliang0508@gmail.com (W.-L. Chen).
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http://dx.doi.org/10.1016/j.ijid.2012.02.010lugdunensis, a coagulase-negative Staphylococcus species (CoNS),
has recently emerged because of its rapidly progressive, invasive
nature in infective endocarditis. Infections with S. lugdunensis tend
to have a more fulminant course, with a condition resembling that of
Staphylococcus aureus infections rather than those caused by CoNS.
Because a detailed phenotypic characterization of S. lugdunensis
endocarditis in patients with CIED has not been addressed, we
sought to analyze cases on this subject and to test whether the defect
of innate immunity may play a permissive role in host susceptibility
to tissue destruction in S. lugdunensis endocarditis.ses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Doppler color ﬂow mapping on transthoracic echocardiography showing a
septic perforation of the interventricular septum (0.8 cm in diameter) with a
measured pulmonary-to-systemic (Qp:Qs) ﬂow ratio of 2.1:1.
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A 66-year-old woman presented to the emergency department
(ED) with shortness of breath, hypotension, and delirium. Three
years previously, a permanent pacemaker programmed in DDD
mode had been implanted because of sick sinus syndrome with
intermittent atrioventricular block. Two months prior to presen-
tation she had undergone a pacing electrode repositioning for the
dislodged atrial lead. In the past 2 weeks she had come to our ED
twice because of intermittent low-grade fever, migratory arthral-
gia, and myalgia. On the ﬁrst visit, the diagnostic workup was
otherwise unrevealing and blood cultures grew CoNS, which were
considered as skin contaminants. On the second visit, three sets of
blood cultures were obtained and all yielded CoNS; none were
regarded as pathogenic at that time. On admission, she had
engorged jugular veins and a harsh holosystolic murmur at the left
sternal border. Laboratory studies are shown in Table 1. An
electrocardiogram showed atrioventricular sequential pacing with
occasional premature ventricular complexes, and a chest radio-
graph revealed signs of pulmonary plethora. A newly-developed
intracardiac shunt was observed (Figure 1); the right ventricle was
of normal size and function and the left ventricular ejection
fraction was 65%. Cardiac catheterization disclosed an elevated
pulmonary artery pressure and a left-to-right interventricular
shunting without signiﬁcant coronary artery disease. Six sets of
blood cultures grew CoNS isolates, further conﬁrmed as S.
lugdunensis. Intravenous antibiotics vancomycin and gentamicin
were given, followed by successful removal of the entire
pacemaker device using an excimer laser-assisted extraction
technique. Microbiological analyses of the small vegetation
adhering to the ventricular lead also yielded S. lugdunensis.
Transvenous temporary pacing and intra-aortic balloon pump
counterpulsation were introduced in order to maintain proper
hemodynamics before a planned surgical repair. Unfortunately the
patient died from sudden cardiac arrest 2 days later.Table 1
Laboratory investigation on admission
Tests Results Reference
Hemoglobin 13.1 g/dl 12.2–14.7 g/dl
Leukocyte count 19.7  109/l 4.5–11.0  109/l
Platelet count 88  109/l 189–287  109/l
Blood urea nitrogen 87 mg/dl 8–25 mg/dl
Creatinine 1.2 mg/dl 0.7–1.5 mg/dl
Sodium 131 mmol/l 135–145 mmol/l
Potassium 4.1 mmol/l 3.3–4.9 mmol/l
Calcium, free 4.2 mg/dl 4.5–5.1 mg/dl
Uric acid 5.9 mg/dl 3–8 mg/dl
Creatine kinase 77 U/l 30–200 U/l
CRP 26.3 mg/dl 0–0.9 mg/dl
ALT 33 U/l 7–53 U/l
AST 41 U/l 11–47 U/l
Total cholesterol 196 mg/dl <200 mg/dl
Triglycerides 167 mg/dl <250 mg/dl
Homocysteine 6 mmol/l 4–12 mmol/l
Creatine kinase MB fraction 67 U/l 30–200 U/l
0–7 U/l
Troponin I 0.02 ng/ml <0.05 ng/ml
D-Dimers 156 mg/l 0–200 mg/l
Fibrinogen 518 mg/dl 150–400 mg/dl
NT-pro-BNP 1933 pg/ml <125 pg/ml
Arterial blood gas (room air)
pH 7.43 7.35–7.45
pO2 66.2 mmHg 80–105 mmHg
pCO2 26.4 mmHg 35–45 mmHg
HCO3
 19.6 mmol/l 22–32 mmol/l
CRP, C-reactive protein; ALT, alanine aminotransferase; AST, aspartate aminotrans-
ferase; NT-pro-BNP, N-terminal prohormone of brain natriuretic peptide.3. Patients and methods
We conducted a systematic literature review covering the
period between 1989 and 2011 using the PubMed, Medline,
Cochrane, and Embase databases. All cases included in the review
had a CIED in use and met the modiﬁed Duke criteria for infective
endocarditis, and all had isolates of S. lugdunensis. The predisposing
factors, echocardiographic manifestations, therapeutic strategies,
and treatment outcomes were evaluated.
Polymorphonuclear neutrophil (PMN) functions were exam-
ined to determine whether the defect of innate immunity may play
a permissive role in host susceptibility to tissue destruction in S.
lugdunensis endocarditis. The PMN oxidative burst was measured
by nitroblue tetrazolium reduction assay in the absence or
presence of endotoxin (lipopolysaccharide from Escherichia coli
055:B5, 10 mg/ml for 15 min). PMNs primed with low doses of
tumor necrosis factor alpha (TNF-a; 100 U/ml) and lipopolysac-
charide (10 ng/ml) were then stimulated with formyl-methionyl-
leucyl-phenylalanine and the oxidative burst was measured using
oxidizing hydroethidine.1 The expression of adhesion molecules
(b2-integrin, CD11b/CD18, and CD62L) on the cell surface of
resting PMNs was also analyzed after stimulation with TNF-a and
lipopolysaccharide.
4. Results
Eleven patients with CIED endocarditis caused by S. lugdunensis
were identiﬁed (Table 2).2–8 Their mean age was 61.7  11.2 years,
and there was a male preponderance (72.7%). Six patients (54.5%) had
undergone re-manipulation of the pacing system within a few
months to years prior to clinical symptoms. The associated conditions
included type 2 diabetes mellitus (n = 2, 18.2%), cutaneous pocket/
pulse generator infection (n = 4, 36.4%), hemodialysis (n = 1, 9.1%),
and resection of kidney neoplasm (n = 1, 9.1%). The median duration
of symptoms before the diagnosis of CIED endocarditis was 60 days.
On echocardiography, vegetations in the CIED were detected in nine
cases (81.8%). Nine patients (81.8%) underwent surgical removal of
the entire device, and one patient received medical treatment alone.
The overall mortality rate was 18.2%. One patient, as described above,
had a septic perforation of the ventricular septum, with a high serum
level of N-terminal prohormone of brain natriuretic peptide (NT-pro-
BNP) in the absence of pump failure. The assessment of PMN
functions demonstrated normal PMN responses to the various stimuli
and normal oxidative burst responses.
Table 2
Cardiac implantable electronic device-related infective endocarditis caused by Staphylococcus lugdunensis
Case Age/sex Associated conditions Duration of
symptom before
diagnosis
Echocardiographic
ﬁndings
Treatment Outcome/
complication
Ref.
1 F/68 Cutaneous infection
5 years earlier
3 weeks 13  12 mm peduncle
vegetation on the wire
Penicillin and gentamicin
(6 weeks); pacemaker removal
by external traction
Recovered/
relapsing
bacteremia
1 year later
2
2 F/68 Battery replacement
1 year earlier
12 months after
manipulation
22 mm vegetation over
the wire
Medical treatment (1 year);
pacemaker removal by
external traction
Recovered 3
3 M/66 None >12 months after
manipulation
23 mm vegetation over
the wire
Cardiopulmonary bypass Died 4
4 M/78 Battery replacement
4 months earlier,
chronic pocket infection
12 months after
manipulation
10 mm vegetation over
the wire
Pacemaker removal by
external traction
Recovered 4
5 M/63 Battery replacement
2 months earlier, chronic
pocket infection
12 months after
manipulation
8 mm vegetation over
the wire
Pacemaker removal by
external traction
Recovered 4
6 M/62 None 1 month 20 mm tricuspid vegetation
and atrial lead vegetation
Cloxacillin and gentamicin;
removal of pacemaker
Recovered 5
7 M/65 Diabetes mellitus,
cutaneous extraction
of a toenail
3 days 5 voluminous vegetations
on the auricular and
ventricular leads
Cloxacillin, gentamicin, and
oﬂoxacin (8 weeks); pacemaker
removal by thoracotomy
Recovered 5
8 M/41 Pulse generator
infection 1 month
earlier
1 month Not available Teicoplanin and fusidic acid
(5 weeks), pristinamycin (4 months);
pacemaker removal by thoracotomy
Recovered/
pulmonary
embolism
4 days after
surgery
6
9 M/61 Nephrectomy due
to neoplasm of the
left kidney
3 months Thrombotic material over
the ventricular pacemaker lead
Ampicillin/sulbactam and gentamicin
(2 weeks); vancomycin and
rifampin (3 weeks)
Recovered 7
10 M/41 Non-ischemic
cardiomyopathy,
diabetes mellitus,
hemodialysis
A few days 36 mm  21 mm,19 mm  15 mm,
and 17 mm  4 mm vegetations
attached to the right atrial
and ventricular lead
Gentamicin and rifampin added to the
vancomycin regimen (6 weeks); surgical
extraction of the pacing apparatus
Recovered 8
11 F/66 Repositioning for
dislodged atrial lead
2 months earlier
2 months An apical ventricular septal
defect
Vancomycin and gentamicin;
pacemaker removal by excimer
laser-assisted extraction
Died Our
patient
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Although most CoNS isolates from blood culture bottles are
considered skin contaminants, some have been identiﬁed as
important pathogens causing bloodstream infections. S. lugdunen-
sis, initially described in 1988 as a separate species of CoNS, is an
important emerging pathogen causing a wide variety of infections.
Clinical observations have shown that S. lugdunensis tends to cause
a fulminant infection such as infective endocarditis, and these
infections are usually indistinguishable from those caused by S.
aureus.9 S. lugdunensis endocarditis generally responds poorly to
conventional antimicrobial therapy alone, and this infection often
results in rapid valvular destruction, myocardial abscess forma-
tion, and septic thromboembolism. Nevertheless, S. lugdunensis is
often mistakenly thought to be a nonpathogenic cutaneous
commensal, leading to high risk of mortality and morbidity.
While some virulence factors have been identiﬁed, the
pathogenetic basis remains unclear. Studies have shown compel-
ling evidence that S. lugdunensis can produce a thermostable DNase
and express a ﬁbrinogen-binding surface protein with consider-
able similarity to clumping factor A of S. aureus, which promotes
bacterial adhesion to immobilized ﬁbrinogen and interferes with
opsonophagocytosis.10 In addition, the production of enzymes that
may act as invasion factors has been observed in S. lugdunensis,
such as fatty acid modifying enzyme, esterase, protease, and
lipase.11 In fact, only about 25% of clinical isolates of S. lugdunensis
produce extracellular slime, which has a role in bacterial
colonization and interferes with the phagocytosis-associated
activities of neutrophils. Therefore, the above-mentioned factors
may not fully account for the tissue destruction capacity. To testwhether the defect of innate immunity may play a permissive role
in host susceptibility to tissue destruction in S. lugdunensis
endocarditis, PMN function was examined in our patient, however
the results were contrary to this pathogenetic hypothesis.
CIED-associated infection has increased considerably over the
past decades, paralleled by the prevalence of its application in
various types of dysrhythmia.12 Several predisposing factors have
been described, but in this case study we found that 54.5% of
patients had undergone re-manipulation of the pacing system
prior to CIED endocarditis. Conceivably, since not all cutaneous
pocket/pulse generator infections are unequivocally in need of
pacing wire removal and not all leads are indispensable for the
patient’s comfortable survival, therapeutic abstention may be
preferable to exposing a patient to a high risk of CIED infection
after re-manipulation of the pacing system.
The high serum level of NT-pro-BNP in our patient without
pump failure is unusual. NT-pro-BNP, a 76-amino acid peptide, was
co-secreted along with brain natriuretic peptide from the cardiac
myocytes in response to excessive myocardial stretch and
increased end-diastolic pressure/volume in the left ventricle.
Plasma natriuretic peptide levels can signiﬁcantly increase in
patients with severe sepsis. Moreover, septic patients in intensive
care units with echocardiographically proven preserved systolic
function can have brain natriuretic peptide levels as high as those
in patients with severe systolic pump failure. Of interest, a recent
study showed that the level of serum NT-pro-BNP may be a
valuable marker for predicting clinical outcomes in patients with
infective endocarditis.13 Although the dismal prognosis of our
patient may plausibly reﬂect NT-pro-BNP as a useful surrogate for
the risk stratiﬁcation of patients with infective endocarditis, the
Y.-T. Tsao et al. / International Journal of Infectious Diseases 16 (2012) e464–e467 e467pathogenetic basis remains undeﬁned and uncertainty exists as to
whether sepsis-induced microcirculatory dysfunction or cytokine-
mediated myocardial injury predominates.
In summary, the identiﬁcation and differentiation of staphylo-
coccal species in a timely manner would allow us to intervene more
aggressively at an earlier stage to prevent unfavorable outcomes.
Although less-appreciated, clinicians should never consider isolates
of S. lugdunensis as contamination in CIED endocarditis. In selected
individuals, therapeutic abstention may be preferable to exposing
patients to a high risk of S. lugdunensis CIED endocarditis due to re-
manipulation of the pacing system. The prognostic value of NT-pro-
BNP warrants further investigations.
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